Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
68
ILMN Quote, Financials, Valuation and Earnings
Last price:
$128.99
Seasonality move
:
8.71%
Day range:
$124.27 - $128.28
52-week range:
$68.70 - $153.06
Dividend yield:
0%
P/E ratio:
28.68x
P/S ratio:
4.71x
P/B ratio:
8.22x
Volume:
948.5K
Avg. volume:
1.9M
1-year change:
-10.15%
Market cap:
$19.6B
Revenue:
$4.4B
EPS (TTM):
$4.46
Analysts' Opinion
-
Consensus RatingIllumina, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 8 Hold ratings, and 1 Sell rating.
-
Price Target DownsideAccording to analysts' consensus price target of $121.39, Illumina, Inc. has an estimated downside of -5.19% from its current price of $128.03.
-
Price Target UpsideAccording to analysts, the highest upside price target is $195.00 representing 52.31% upside increase from its current price of $128.03.
Fair Value
-
According to the consensus of 16 analysts, Illumina, Inc. has -5.19% downside to fair value with a price target of $121.39 per share.
ILMN vs. S&P 500
-
Over the past 5 trading days, Illumina, Inc. has underperformed the S&P 500 by -1.49% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Illumina, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Illumina, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Illumina, Inc. reported revenues of $1.1B.
Earnings Growth
-
Illumina, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Illumina, Inc. reported earnings per share of $0.97.
Enterprise value:
20.9B
EV / Invested capital:
4.21x
Price / LTM sales:
4.71x
EV / EBIT:
24.86x
EV / Revenue:
4.87x
PEG ratio (5yr expected):
-2.13x
EV / Free cash flow:
21.01x
Price / Operating cash flow:
20.31x
Enterprise value / EBITDA:
18.73x
Gross Profit (TTM):
$2.9B
Return On Assets:
11.43%
Net Income Margin (TTM):
16.41%
Return On Equity:
30.55%
Return On Invested Capital:
14.3%
Operating Margin:
21.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $4.5B | $4.4B | $4.3B | $1.1B | $1.1B | |
| Gross Profit | $2.7B | $2.8B | $2.9B | $745M | $732M | |
| Operating Income | -$93M | $974M | $839M | $548M | $231M | |
| EBITDA | $335M | $1.4B | $1.1B | $618M | $298M | |
| Diluted EPS | -$7.12 | -$10.00 | $4.46 | $4.41 | $0.97 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.5B | $2.5B | $2.5B | $2.4B | $2.8B | |
| Total Assets | $15.1B | $11.3B | $10.1B | $6B | $6.2B | |
| Current Liabilities | $914M | $2.7B | $1.5B | $975M | $2B | |
| Total Liabilities | $4.5B | $4.5B | $4.2B | $3.9B | $3.8B | |
| Total Equity | $10.6B | $6.7B | $5.9B | $2.1B | $2.4B | |
| Total Debt | $2.5B | $2.5B | $2.2B | $2.6B | $2.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $401M | $696M | $1.1B | $316M | $284M | |
| Cash From Investing | -$248M | -$215M | -$211M | -$41M | -$51M | |
| Cash From Financing | -$227M | -$549M | -$728M | -$332M | -$115M | |
| Free Cash Flow | $168M | $465M | $993M | $203M | $253M | |
ILMN
Sector
Market Cap
$19.6B
$28.8M
Price % of 52-Week High
83.65%
51.13%
Dividend Yield
0%
0%
Shareholder Yield
5.11%
-1.32%
1-Year Price Total Return
-10.15%
-20.64%
Beta (5-Year)
1.438
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$128.64
200-day SMA
Buy
Level
$94.63
Bollinger Bands (100)
Buy
Level
93.43 - 116.05
Chaikin Money Flow
Buy
Level
503.9M
20-day SMA
Buy
Level
$124.22
Relative Strength Index (RSI14)
Buy
Level
64.54
ADX Line
Buy
Level
31.63
Williams %R
Neutral
Level
-27.3754
50-day SMA
Buy
Level
$109.71
MACD (12, 26)
Buy
Level
5.33
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
419M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.0993)
Buy
CA Score
(Annual)
Level (-0.0615)
Buy
Beneish M-Score
(Annual)
Level (-4.3389)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.1397)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Stock Forecast FAQ
In the current month, ILMN has received 7 Buy ratings 8 Hold ratings, and 1 Sell ratings. The ILMN average analyst price target in the past 3 months is $121.39.
-
Where Will Illumina, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Illumina, Inc. share price will drop to $121.39 per share over the next 12 months.
-
What Do Analysts Say About Illumina, Inc.?
Analysts are divided on their view about Illumina, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Illumina, Inc. is a Sell and believe this share price will rise from its current level to $80.00.
-
What Is Illumina, Inc.'s Price Target?
The price target for Illumina, Inc. over the next 1-year time period is forecast to be $121.39 according to 16 Wall Street analysts, 7 of them rate the stock a Buy, 1 rates the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is ILMN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Illumina, Inc. is a Hold. 8 of 16 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ILMN?
You can purchase shares of Illumina, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Illumina, Inc. shares.
-
What Is The Illumina, Inc. Share Price Today?
Illumina, Inc. was last trading at $128.99 per share. This represents the most recent stock quote for Illumina, Inc.. Yesterday, Illumina, Inc. closed at $128.03 per share.
-
How To Buy Illumina, Inc. Stock Online?
In order to purchase Illumina, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ILMN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ILMN
Sector
P/E ratio
28.68x
23.71x
PEG ratio
-2.13x
-0.01x
P/B ratio
8.22x
1.84x
Price / LTM sales
4.71x
1.60x
Growth Metrics
ILMN
Sector
Revenue growth
0.28%
4.85%
Earnings growth
-77.9%
11.15%
Revenue (5-year growth)
4.3%
6.45%
Earnings forecast
$1.17
-$0.20
Profitability
ILMN
Sector
Profitability FY 2024
$2.9B
$3.6M
Return on invested capital
14.3%
-30.98%
Return on assets
11.43%
-27.62%
Return on equity
30.55%
-36.69%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Jan
29
Balance Sheet
ILMN
Sector
Total cash
$1.3B
$27.2M
Short term investments
$93M
$25.7M
Total assets
$6.3B
$79.7M
Long term debt
$2.5B
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 0.06% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 2.97% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
